October 4, 2011
Following the completion of the acquisition of Nycomed by Takeda Pharmaceutical at the end of September, rating companies downgraded Takeda on September 3. Rating and Investment Information, Inc. (R&I) downgraded the rating from AAA to AA+. Standard & Poor’s Ratings...read more